Condition
Chikungunya Virus Infection clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Chikungunya Virus Infection clinical trials that are recruiting, at sites in 4 countries (most in French Guiana (2), France (1), Mayotte (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 4Countries
All recruiting trials (2)
-
Plasma transfusion to protect newborns exposed to chikungunya from brain inflammation
This trial will test whether giving plasma from a recent chikungunya-infected donor to newborns whose mothers had chikungunya around delivery helps prevent encephalitis or encephalopathy in the first five days of life.
-
Assessing the effectiveness and safety of a chikungunya vaccine in at-risk populations
This study is testing a chikungunya vaccine to see if it helps protect seniors and people with other health issues during an outbreak.
Related topics
Quick answers
How many Chikungunya Virus Infection clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in French Guiana (2 trials), France (1 trial), Mayotte (1 trial), Reunion (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.